Transcept Pharmaceuticals, Inc. was a U.S. specialty pharmaceutical company focused on central nervous system treatments. Its principal product was Intermezzo (zolpidem tartrate…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Transcept Pharmaceuticals →Already a subscriber? Sign in
Xcout Intel tracks Transcept Pharmaceuticals continuously — this profile deepens as new filings, funding, people and hiring data arrive.